Postdoctoral Researcher

UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.

UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.

www.uhn.ca

Position Summary
A postdoctoral fellowship is available in the laboratories of Dr. Trevor Pugh, PhD, FACMG and Dr. Suzanne Trudel MD at the Princess Margaret Cancer Centre / University Health Network in Toronto, Canada. Located in the MaRS Centre in the heart of the downtown Discovery District, we are an integral component of multiple translational genomics projects and platforms including the Cancer Genomics Program, Tumour Immunotherapy Program, Princess Margaret Genomics Centre. This position will support fellows wishing to lead the collaborative, clinically-oriented myeloma genome analysis projects.

This position is an opportunity for scientifically creative, computationally-inclined individuals with a strong cancer biology background to join our team focused on developing blood-based precision medicine approaches for Multiple Myeloma (MM). This project leverages whole-genome sequencing (WGS) of cell-free DNA (cfDNA) to enable non-invasive detection, molecular characterization, and longitudinal monitoring of MM. The successful candidate will lead efforts in integrating cfDNA WGS data with clinical and bone marrow biopsy data, with the goal of reconstructing the MM genome, identifying actionable mutations, and developing novel biomarkers for minimal residual disease (MRD) and treatment resistance. This position offers the opportunity to work with cutting-edge sequencing technologies, including 200X cfWGS, and innovative computational tools in a translational research environment.

Candidates must have a PhD or MD with specialization in genetics, molecular biology, bioinformatics, or computer science as well as hands-on experience in the use of Unix/Linux, R/Matlab, and statistical approaches to analyze and visualize genome-scale data sets. Preferred but not required are expertise in Python and Java programming, web and database development, industry software development practices (version control, etc.), and expertise using tools for analyzing next-generation sequencing data such as the Genome Analysis Toolkit, the Picard suite of tools, and mutation detection algorithms. Candidates must be highly motivated, possess excellent organizational, problem-solving and communication skills (both verbal and written), and should have prior publications in cancer, genomics, immunology, and/or biomedical journals.

Applicants should apply with a curriculum vitae and a cover letter in PDF format describing specific disease areas of interest to you, how your past experience may complement training in computational cancer genomics, and your future career goals. Applicants will be expected to apply for UHN's Canada Leads initiative to support this opportunity. A link to an active github repository showing past work would be viewed favourably.

Duties

UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.

Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.

UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.

We thank all applicants for their interest, however, only those selected for further consideration will be contacted.